<DOC>
	<DOCNO>NCT00074763</DOCNO>
	<brief_summary>Objectives : - Determine correct count increment autologous transfuse platelet store cryopreservation ThromboSol . - Determine ability autologous platelet store cryopreservation ThromboSol correct thrombocytopenia .</brief_summary>
	<brief_title>Comparing Fresh Random Platelets Autologous Cryopreserved Thrombosol Treated Autologous Platelets</brief_title>
	<detailed_description>Platelets important component blood . Transfusions platelets help control bleed thrombocytopenic patient . Using standard blood banking procedure , platelet store 5 day . This help decrease risk contamination bacteria . Currently , possible use cryopreserved ( frozen ) platelet platelet damage freeze process . Therefore , long-term banking platelet autologous donation ( store platelet give back late time ) possible . ThromboSol new solution design allow platelet freeze without damage . The use ThromboSol may allow long-term banking platelet and/or autologous donation . During period cancer remission enough platelet blood , undergo apheresis procedure collect platelet . This procedure similar donate plasma blood bank . You 6 apheresis procedure ( different day ) collect 6 unit autologous platelet transfuse back . The platelet collect frozen ThromboSol store may give back platelet count drop certain level . The frozen platelet store 18 month . When platelet count drop certain level , schedule platelet transfusion part standard care . Before transfusion blood drawn ( around 1-2 teaspoon ) check number platelet blood . You randomly assign ( toss coin ) either receive standard platelet transfusion ThromboSol-preserved autologous platelet transfusion . After transfusion , additional blood drawn ( around 1-2 teaspoon ) check number platelet blood . These procedure repeat time require platelet transfusion . However , randomly assign . Each time receive additional platelet transfusion , assign group different one . The type transfusion alternate . For instance , randomly assign receive frozen platelet first transfusion , receive standard transfusion next , back frozen third transfusion . If develop side effect ThromboSol-preserved autologous platelet transfusion number platelet blood increase infusion preserve platelet , take study give standard platelet transfusion . This investigational study . Up 54 participant take part study . All enrol UTMDACC .</detailed_description>
	<criteria>1 ) 1 . Patients remission ALL , CLL , AML , CML , MDS allow participate program platelet count &gt; 150K , hemoglobin level least 8.0g/dl . The patient receive autologous platelet cryopreserved ThromboSol fresh random platelet ( FRP ) whenever need transfusion determine clinically indicate physician ( ) . 1 ) Patients detectable circulate malignant cell ongoing marrow involvement tumor eligible .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Leukemia</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>ALL</keyword>
	<keyword>CLL</keyword>
	<keyword>AML</keyword>
	<keyword>CML</keyword>
	<keyword>MDS</keyword>
	<keyword>Remission</keyword>
	<keyword>Hematologic Disorder</keyword>
	<keyword>Transfusion</keyword>
	<keyword>Thrombosol</keyword>
	<keyword>Autologous Platelet Transfusion</keyword>
	<keyword>Platelet Transfusion</keyword>
	<keyword>Single donor platelet apheresis</keyword>
	<keyword>Cryopreservation</keyword>
	<keyword>Thrombocytopenia</keyword>
</DOC>